BERLIN-CHEMIE develops, produces and sells pharmaceutical products

BERLIN-CHEMIE is a German subsidiary of the MENARINI Group, which has been occupying a leading position in the Italian pharmaceutical market for many years. The company, which was formed in 1886 and is headquartered in Florence, was developed over the generations to become a global, owner-managed pharmaceutical company.

MENARINI pursues two strategic objectives: research and internationalization. Both endeavors enable innovative products to be used successfully to the satisfaction of patients throughout the world. The MENARINI Group enjoys an outstanding reputation worldwide as an efficient and reliable partner. This applies both to the development of new drugs and to the communication of scientific insights.

BERLIN-CHEMIE also benefits from this partnership-based way of thinking. We consistently carry on the group strategy in our remit. BERLIN-CHEMIE/MENARINI Albania has started the activities from 2000 with the focus on cardiology, endocrinology, gastroenterology and OTC products.

The representative office in Tirana opened in 2004 with qualified staff and good relationship with doctors.

Year by year we have offered our assistance to the development of professional skills of the doctors and introducing in the market new generated products with contemporary quality.

In cardiology we offer new molecules of each antihypertensive class.

In diabetology the main products of the treatment of diabetes mellitus.

In OTC modern and contemporary products with good quality.

Further topics